Suzhou Nanomicro Technology Co., Ltd. (SHA:688690)

China · Delayed Price · Currency is CNY

40.77

-0.70 (-1.69%)

May 28, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Biopharmaceutical	611.77M	-					96.81M	58.64M	37.40M
Biopharmaceutical Growth	-	-					65.09%	56.79%	-
Analysis and Testing	269.33M	-					-	-	-
Flat Panel Display	34.22M	-					29.32M	23.68M	19.71M
Flat Panel Display Growth	-	-					23.83%	20.10%	-
in Vitro Diagnostic	7.78M	-					-	-	-
Unallocated Others	1.59M	-					-	-	-
Total	924.69M	-					126.12M	82.31M	57.11M
Total Growth	-	-					53.22%	44.12%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	840.60M	-					113.57M	73.82M	52.44M
China Growth	-	-					53.86%	40.77%	-
Overseas	84.09M	-					12.55M	8.50M	4.68M
Overseas Growth	-	-					47.71%	81.72%	-
Total	924.69M	-					126.12M	82.31M	57.11M
Total Growth	-	-					53.22%	44.12%	-

Source: S&P Global Market Intelligence.